Back
Aligos Therapeutics Quote, Financials, Valuation and Earnings
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Buy
67
ALGS
Aligos Therapeutics
Last Price:
19.46
Seasonality Move:
0%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.Aligos Therapeutics Price Quote
$19.46
Aligos Therapeutics Key Stats
Buy
67
Aligos Therapeutics (ALGS)
is a Buy
Day range:
$15.66 - $20.44
52-week range:
$6.76 - $30.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
17.67
P/B ratio:
1.39%
Volume:
625K
Avg. volume:
318.3K
1-year change:
31.49%
Market cap:
$69.8M
Revenue:
$15.5M
EPS:
$-17.11
How Much Does Aligos Therapeutics Make?
-
How Much Are Aligos Therapeutics's Sales Annually?
ALGS Revenues are $15.5M -
How Much Profit Does Aligos Therapeutics's Make A Year?
ALGS net income is -$87.7M
Is Aligos Therapeutics Growing As A Company?
-
What Is Aligos Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.61% -
What Is Aligos Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Aligos Therapeutics Stock Price Performance
-
Did Aligos Therapeutics Stock Go Up Last Month?
Aligos Therapeutics share price went up by 169.16% last month -
Did ALGS's Share Price Rise Over The Last Year?
ALGS share price rose by 31.49% over the past 1 year
What Is Aligos Therapeutics 52-Week High & Low?
-
What Is Aligos Therapeutics’s 52-Week High Share Price?
Aligos Therapeutics has traded as high as $30.00 over the past 52 weeks -
What Is Aligos Therapeutics’s 52-Week Low Share Price?
Aligos Therapeutics has traded as low as $6.76 over the past 52 weeks
Aligos Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Aligos Therapeutics?
-
How Much Debt Does Aligos Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Aligos Therapeutics Have?
Cash and short term investments quarterly total is $74.9M -
What Is Aligos Therapeutics’s Book Value Per Share?
Book value per share is 15.07
Is Aligos Therapeutics Cash Flow Positive?
-
What Is ALGS Cash Flow From Operations?
Cash flow from operations (TTM) is -$85M -
What Is Aligos Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $88.2M -
What Is Aligos Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$38.3M
Aligos Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
ALGS return on invested capital is -118.75% -
What Is Aligos Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -68.4% -
What Is ALGS Return On Equity?
ROE is a measure of profitability and is -118.75%
Aligos Therapeutics Earnings Date & Stock Price
-
What Is Aligos Therapeutics's Stock Price Today?
A single share of ALGS can be purchased today for 19.46 -
What Is Aligos Therapeutics’s Stock Symbol?
Aligos Therapeutics trades on the nasdaq under the ticker symbol: ALGS -
When Is Aligos Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Aligos Therapeutics is scheduled on March 12, 2025 -
When Is ALGS's next ex-dividend date?
Aligos Therapeutics's next ex-dividend date is November 15, 2024 -
How To Buy Aligos Therapeutics Stock?
You can buy Aligos Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Aligos Therapeutics Competitors
-
Who Are Aligos Therapeutics's Competitors?
Below is a list of companies who compete with Aligos Therapeutics or are related in some way:
Aligos Therapeutics Dividend Yield
-
What Is ALGS Dividend Yield?
Aligos Therapeutics’s dividend yield currently is 0% -
What Is Aligos Therapeutics’s Payout Ratio?
Aligos Therapeutics’s payout ratio is 0% -
When Did Aligos Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is Aligos Therapeutics’s Dividend Per Share?
Aligos Therapeutics pays a dividend of $0.00 per share
Aligos Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -131.7% |
| Revenue: | -60.82% | 280.7% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 103.33 |
| Upside from Last Price: | 431% |